Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Digital Health Trends 2024 - Implications for Research and Patient Care

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE

Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
Creating a framework for a successful launch: Science sells
William McClellan, Center of Excellence Leader, Launch Excellence
Maneesh Gupta, Senior Principal, Brand & Commercial Strategy, IQVIA
Jul 30, 2018
  • Blogs
  • Creating a framework for a successful launch: Science sells

Incivek’s disease awareness campaign was a key product differentiator that enabled the company a unique position in the HCV market.

This is the second blog in the five blog series: Creating a framework for a successful launch. IQVIA analyzed launches globally to identify common launch challenges and pitfalls. Four launch archetypes were identified, "science sells", "market shaping", "who benefits" and "emphasize the difference", each had very specific critical success factors.

For the "science sells" archetype, where there is a high unmet need in the market and high product differentiation the critical success factors are:

  • Disease/MOA awareness pre-launch
  • Optimized pricing
  • Risk mitigation plan
  • Public policy activity
  • Patient advocacy group engagement

Additional challenges for emerging biopharma include:

  • Early preparation for disease awareness
  • Appropriately valuing science

In this blog we examine the example of:

Science sells: Vertex Pharmaceuticals' first launch in the hepatitis C market

Incivek (telaprevir) is a protease inhibitor and was approved in the U.S. and Europe for the treatment of hepatitis C infection in 2011. 

The window of opportunity for success in a drug launch is very short. The launch trajectory is set in the first 12 to 16 weeks after the launch, and only around a fifth of brands can change their trajectory once the drug hits the market. This means that there is a huge benefit in preparing the market before the launch. 

Large pharmaceutical organizations have many resources to call upon in the pre-launch period, This includes more capital, more people, more experience, and more opportunities to start preparation early, sometimes up to five years before launch. In comparison, an emerging biopharma company may only be able to begin preparation around two years before a launch. Therefore, emerging biopharma have to choose how to use their resources more carefully.

Building the tools

Not only was Vertex facing a new market with an all-new commercial team, it was up against a top-ten biopharma company with a product in the same class that was launched within 10 days of Incivek. 

However, Vertex had two benefits. Firstly, the hepatitis C area was one of major unmet medical need at the time of the Incivek launch, providing a market with many opportunities. In 2011, there were around 3 million people infected with hepatitis C in the U.S., with around 78% of them unaware of the infection. And secondly, Vertex created a key differentiator – its disease awareness campaign. 

The pre-launch disease awareness campaign targeted both physicians and patients. For patients, its aim was to provide scientific information and health education with a patient voice. The campaign featured patient stories and videos, a hepatitis C screener and practical advice, through an unbranded site. Vertex also initiated partnerships with HCV advocacy groups more than a year before approval. 

For physicians, Vertex created an unbranded site as well, to jumpstart non-product scientific dialogue and provide access to the latest thinking from thought leaders. The site was designed to make it easy for HCPs to share information with their colleagues. 

The campaign meant that Vertex could become recognized for offering products and solutions to the hepatitis C community, from the perspectives of both healthcare professionals and patients, even before Incivek was on the market. 

The success story

By making the most of its market need and key differentiator, Vertex managed to capture around a 75% share of the market, especially for those with an urgent need for treatment.

While Incivek’s disease awareness campaign was a key product differentiator that enabled the company a unique position in the HCV market, it is important to remember that this was only one element of a much larger launch strategy. Other critical success factors were also important in the launch of Incivek.

To get more insight into the “science sells” archetype visit: A framework for successful biopharma launches for the recorded webinar, supported by a slide presentation.

More about the Authors:

  • William McClellan
    Center of Excellence Leader, Launch Excellence
    William is an expert in the field of pharmaceutical launch excellence with over 20 years of experience. He leads the Launch Center of Excellence for the U.S. at IQVIA where he focuses on launch readiness, tracking, and performance diagnostics utilizing patient data such as predictive modeling and quantitative and qualitative research.

Contributor:

  • Maneesh Gupta
    Senior Principal, Brand & Commercial Strategy, IQVIA 
    Maneesh is a Senior Principal with Consulting Services at IQVIA. He focuses on launch, brand, and commercial strategy. He has been helping organizations excel at launches and become more customer centric for more than 20 years. His papers on these topics have been published in several industry journals.
Contact Us